93 related articles for article (PubMed ID: 16510178)
1. Lectin-conjugated PEG-PLA nanoparticles: preparation and brain delivery after intranasal administration.
Gao X; Tao W; Lu W; Zhang Q; Zhang Y; Jiang X; Fu S
Biomaterials; 2006 Jun; 27(18):3482-90. PubMed ID: 16510178
[TBL] [Abstract][Full Text] [Related]
2. Intracellular delivery of nanoparticles of an antiasthmatic drug.
Surti N; Naik S; Bagchi T; Dwarkanath BS; Misra A
AAPS PharmSciTech; 2008; 9(1):217-23. PubMed ID: 18446484
[TBL] [Abstract][Full Text] [Related]
3. Brain delivery of vasoactive intestinal peptide enhanced with the nanoparticles conjugated with wheat germ agglutinin following intranasal administration.
Gao X; Wu B; Zhang Q; Chen J; Zhu J; Zhang W; Rong Z; Chen H; Jiang X
J Control Release; 2007 Aug; 121(3):156-67. PubMed ID: 17628165
[TBL] [Abstract][Full Text] [Related]
4. Nose-to-brain drug delivery by nanoparticles in the treatment of neurological disorders.
Ong WY; Shalini SM; Costantino L
Curr Med Chem; 2014; 21(37):4247-56. PubMed ID: 25039773
[TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of lectin-conjugated chitosan fluorescent nanoparticles.
Liu J; Zhang L; Wang C; Xu H; Zhao X
Mol Biosyst; 2010 Jun; 6(6):954-7. PubMed ID: 20379582
[TBL] [Abstract][Full Text] [Related]
6. UEA I-bearing nanoparticles for brain delivery following intranasal administration.
Gao X; Chen J; Tao W; Zhu J; Zhang Q; Chen H; Jiang X
Int J Pharm; 2007 Aug; 340(1-2):207-15. PubMed ID: 17499948
[TBL] [Abstract][Full Text] [Related]
7. Solanum tuberosum lectin-conjugated PLGA nanoparticles for nose-to-brain delivery: in vivo and in vitro evaluations.
Chen J; Zhang C; Liu Q; Shao X; Feng C; Shen Y; Zhang Q; Jiang X
J Drug Target; 2012 Feb; 20(2):174-84. PubMed ID: 21992548
[TBL] [Abstract][Full Text] [Related]
8. Lactoferrin conjugated PEG-PLGA nanoparticles for brain delivery: preparation, characterization and efficacy in Parkinson's disease.
Hu K; Shi Y; Jiang W; Han J; Huang S; Jiang X
Int J Pharm; 2011 Aug; 415(1-2):273-83. PubMed ID: 21651967
[TBL] [Abstract][Full Text] [Related]
9. Attenuation of kindled seizures by intranasal delivery of neuropeptide-loaded nanoparticles.
Kubek MJ; Domb AJ; Veronesi MC
Neurotherapeutics; 2009 Apr; 6(2):359-71. PubMed ID: 19332331
[TBL] [Abstract][Full Text] [Related]
10. Lectin-conjugated microspheres for eradication of Helicobacter pylori infection and interaction with mucus.
Adebisi AO; Conway BR
Int J Pharm; 2014 Aug; 470(1-2):28-40. PubMed ID: 24792977
[TBL] [Abstract][Full Text] [Related]
11. Lactoferrin-modified PEG-co-PCL nanoparticles for enhanced brain delivery of NAP peptide following intranasal administration.
Liu Z; Jiang M; Kang T; Miao D; Gu G; Song Q; Yao L; Hu Q; Tu Y; Pang Z; Chen H; Jiang X; Gao X; Chen J
Biomaterials; 2013 May; 34(15):3870-81. PubMed ID: 23453061
[TBL] [Abstract][Full Text] [Related]
12. Intranasal Delivery of Functionalized Polymeric Nanomaterials to the Brain.
Zha S; Wong KL; All AH
Adv Healthc Mater; 2022 Jun; 11(11):e2102610. PubMed ID: 35166052
[TBL] [Abstract][Full Text] [Related]
13. Nasal administration of nanoencapsulated geraniol/ursodeoxycholic acid conjugate: Towards a new approach for the management of Parkinson's disease.
de Oliveira Junior ER; Truzzi E; Ferraro L; Fogagnolo M; Pavan B; Beggiato S; Rustichelli C; Maretti E; Lima EM; Leo E; Dalpiaz A
J Control Release; 2020 May; 321():540-552. PubMed ID: 32092370
[TBL] [Abstract][Full Text] [Related]
14. Nose to brain delivery of rotigotine loaded chitosan nanoparticles in human SH-SY5Y neuroblastoma cells and animal model of Parkinson's disease.
Bhattamisra SK; Shak AT; Xi LW; Safian NH; Choudhury H; Lim WM; Shahzad N; Alhakamy NA; Anwer MK; Radhakrishnan AK; Md S
Int J Pharm; 2020 Apr; 579():119148. PubMed ID: 32084576
[TBL] [Abstract][Full Text] [Related]
15. Intranasal delivery of targeted polyfunctional gold-iron oxide nanoparticles loaded with therapeutic microRNAs for combined theranostic multimodality imaging and presensitization of glioblastoma to temozolomide.
Sukumar UK; Bose RJC; Malhotra M; Babikir HA; Afjei R; Robinson E; Zeng Y; Chang E; Habte F; Sinclair R; Gambhir SS; Massoud TF; Paulmurugan R
Biomaterials; 2019 Oct; 218():119342. PubMed ID: 31326657
[TBL] [Abstract][Full Text] [Related]
16. Nose-to-brain delivery of lipid-based nanosystems for epileptic seizures and anxiety crisis.
Costa C; Moreira JN; Amaral MH; Sousa Lobo JM; Silva AC
J Control Release; 2019 Feb; 295():187-200. PubMed ID: 30610952
[TBL] [Abstract][Full Text] [Related]
17. Focused ultrasound combined with microbubble-mediated intranasal delivery of gold nanoclusters to the brain.
Ye D; Zhang X; Yue Y; Raliya R; Biswas P; Taylor S; Tai YC; Rubin JB; Liu Y; Chen H
J Control Release; 2018 Sep; 286():145-153. PubMed ID: 30009893
[TBL] [Abstract][Full Text] [Related]
18. Delivery of siRNA to the brain using a combination of nose-to-brain delivery and cell-penetrating peptide-modified nano-micelles.
Kanazawa T; Akiyama F; Kakizaki S; Takashima Y; Seta Y
Biomaterials; 2013 Dec; 34(36):9220-6. PubMed ID: 23992922
[TBL] [Abstract][Full Text] [Related]
19. Low molecular weight protamine-functionalized nanoparticles for drug delivery to the brain after intranasal administration.
Xia H; Gao X; Gu G; Liu Z; Zeng N; Hu Q; Song Q; Yao L; Pang Z; Jiang X; Chen J; Chen H
Biomaterials; 2011 Dec; 32(36):9888-98. PubMed ID: 21937105
[TBL] [Abstract][Full Text] [Related]
20. Multidimensional autophagy nano-regulator boosts Alzheimer's disease treatment by improving both extra/intraneuronal homeostasis.
Li Y; Yang P; Meng R; Xu S; Zhou L; Qian K; Wang P; Cheng Y; Sheng D; Xu M; Wang T; Wu J; Cao J; Zhang Q
Acta Pharm Sin B; 2024 Mar; 14(3):1380-1399. PubMed ID: 38486986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
